Expression of Fas ligand is an early event in colorectal carcinogenesis

Journal of Surgical Oncology

Volumn 76, Issue 1, 2001, Pages 63-68

  Masaaki Shimoyama, Tatsuo Kanda ^a   Liu, Lili ^a   Koyama, Yu ^a   Suda, Takeyasu ^a   Sakai, Yasuo ^a   Hatakeyama, Katsuyoshi ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Colorectal adenoma; Colorectal cancer; FasL; Immunohistochemistry

Indexed keywords

FAS ANTIGEN; LIGAND;

ADULT; AGED; ARTICLE; CANCER GRADING; COLON ADENOMA; COLON CARCINOGENESIS; COLORECTAL CANCER; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA; ADENOMA; COLORECTAL NEOPLASMS; FAS LIGAND PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; MEMBRANE GLYCOPROTEINS; NEOPLASM STAGING;

EID: 0035142995     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9098(200101)76:1<63::AID-JSO1011>3.0.CO;2-C     Document Type: Article

References (23)

1. The Fas death factor
2. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
3. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen
4. Human Fas ligand: Gene structure, chromosomal location and species specificity
5. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death
6. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family
7. Apoptosis by death factor
8. A role for CD95 ligand in preventing graft rejection
9. Fas ligand-induced apoptosis as a mechanism of immune privilege
10. Melanoma cell expression of Fas (Apo-1/CD95) ligand: Implications for tumor immune escape
11. Lymphocyte apoptosis induced by CD95(apo-1/Fas) ligand-expressing tumor cells - A mechanism of immune evasion?
12. Human lung carcinomas express Fas ligand
13. Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer
14. Expression of Fas ligand by human gastric adenocarcinomas: A potential mechanism of immune escape in stomach cancer
15. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand
16. Fas Ligand expression in primary colon adenocarcinomas: Evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer
17. Human colon cancer cells express the functional Fas ligand
18. Expression of Fas ligand in liver metastases of human colonic adenocarcinomas
19. Overexpression of Fas ligand (FasL) during malignant transformation in the large bowel and in Barrett's metaplasia of the esophagus
20. Fas counter-attack-the best form of tumor defense?
21. Fas ligand: A sensor for DNA damage critical in skin cancer etiology
22. The hallmarks of cancer